å¤ç®æ¼±ç³ã®ãããããèªããã³ã«æããã ãã©ããã®å çãã¬ãã§ã¡ã³ã¿ã«ã¯ãªããã¯è¡ã£ã¦ãã100ï¼ æ»ãªãã«æ¸ãã ããªã é è¯ããã¦ãéã«èªåã®ç½ªæªæãè«ççã«çµã¿ç«ã¦ã¡ãã£ã¦ã Kã®èªæ®ºï¼èªåãåå ã£ã¦æãè¾¼ãã§ãèªåã§èªåã追ãè©°ãã¦ãããã ããå®å ¨ã«èªç¥ã®æªã¿ã ã ç¾ä»£ã®ç²¾ç¥ç§å»ãè¦ãããå¼·è¿«è¦³å¿µï¼æãã¤ç¶æ ï¼èªè²¬æèã£ã¦å³è¨ºæãã¦ãSSRIåºãã¦è¨ºææ¸æ¸ãã¦èªç¥è¡åçæ³å§ããã¬ãã«ã ã¾ãå診ã§ãKããã®æ»ã¯ããªãã®ããã ããããªãã§ãããã£ã¦è¨ãããããå çæ³£ãã¦ãã ãã ãããªãã¯è£åã£ãããããªãã¦ããã æãã¦ãã¾ã£ãã ããªãã§ããã¨ãè¨ãããããå¿ãã¡ãã£ã¨æºããã ã¯ããªãã ãã ãããã°ã«ã¼ãçæ³ã¨ãã«éã£ã¦ãåãããã«éå»ã«èª°ããæ»ãªãã¦ãã¾ã£ãç½ªæªæã§è¦ããã§ã人ã¨è©±ãã°ãè¦ããã§ãã®ã¯ä¿ºã ããããªããã ã£ã¦æ°ã¥ãããããããªãã å çã£ã¦çµå±ã誰ã¨ãæ¬é³ã§è©±ãã¦ãªãã£
ï¼ï¼æ³ã®å¥³åä¸å¦çããã¤ã¨ãããå§ããããè¡ãéãã§æé£éå®³ï¼æé£çï¼ã«ãªã£ããç é¢ã®ç²¾ç¥ç§ã«å ¥é¢å¾ãå®¶ã«å¸°ããããã¨ç¹æ»´ãæãã¨ããããã«ä½ãææãããï¼ï¼æ¥éãç¶ããããããã¾ã§ããå¿ è¦ãæ¬å½ã«ãã£ãã®ããã大人ã«ãªã£ã女æ§ã¯ç é¢ãç¸æã«è¨´è¨ãèµ·ããããã®ã»ã©å¤æ±ºãè¨ã渡ãããã彼女ã«ã¯ãè£å¤ãéãã¦ç¤¾ä¼ã«è¨´ããããã¨ããã£ããï¼å ±åéä¿¡ï¼å¸å·äº¨ï¼ â½ï¼äººããã㧠女æ§ã¯æ¦ç°ç¾éããï¼ï¼ï¼ï¼ãæ¦ç°ããã¯ä¸å¦ï¼å¹´ã ã£ãï¼ï¼ï¼ï¼å¹´ï¼æãããããã¤ã¨ãããå§ãããé£ã¹ããã¨ã¸ã®æå¦åå¿ãå¼·ããªããï¼å¹´ã«é²ç´ããå¾ã®ï¼æã«ã¯ï¼ï¼ï¼ã»ã³ãã®èº«é·ã§ä½éãï¼ï¼ããã¾ã§æ¸å°ãä½èª¿ãæªåãããããæ±äº¬é½å ã«ããç·åç é¢ã®ææ¥æç²¾ç¥ç§ç æ£ã«å ¥é¢ããã å ¥é¢ããï¼æ¥å¾ãæ¦ç°ããã¯é³æ¥½ãè´ããã¨ãèªããããªãçæ´»ãç é¢å´ã®å¯¾å¿ã«ç´å¾ã§ãããç¹æ»´ãèªåã§æãããæ¦ç°ããã説å¾ã«å¿ããªããããæ å½å»ã¯èº«ä½ææãæ
以åã®è¨äºãä½ã³ã¬ã¹ããã¼ã«ã¯æ´åæ§ãé«ãããã§æ¸ããããã«ãä½ã³ã¬ã¹ããã¼ã«ã¯äººæ ¼ã«å½±é¿ããæ»ææ§ãé«ããå¯è½æ§ãããã¾ããããã ã¨ããããã¹ã¿ãã³ã«ããã³ã¬ã¹ããã¼ã«ãä½ä¸ãã人ã¯äººæ ¼ãå¤ãã£ã¦ãã¾ãã®ã§ããããï¼å®éã«å¤ãã£ã¦ãã¾ã人ã¯ããããã§ãã ä»åã¯èªå·±ç³åã®12人ã®å ±åã§ãã1 種é¡ä»¥ä¸ã®ã¹ã¿ãã³ãæç¨ä¸ã«æ°åãè¡åã®å¤åãçµé¨ããã¨æ¬äººã¾ãã¯å®¶æãç¹å®ããåè¨ 12 åã®è¢«é¨è ããã³/ã¾ãã¯å®¶æ (被é¨è ãæ»äº¡ããå ´å) ãç ç©¶ã°ã«ã¼ãã«é£çµ¡ããèª¿æ»æ å ±ãæä¾ãã¾ããã çä¾1ãä¹¾ç¬ã®æ¢å¾æ´ããããç²¾ç¥ç¾æ£ã®æ¢å¾æ´ãå®¶ææ´ã®ãªã40代ã®å°éè·ç·æ§ãé«èè¡çï¼ç·ã³ã¬ã¹ããã¼ã«262 mg/dLã䏿§èèª123 mg/dLãHDLã³ã¬ã¹ããã¼ã«35 mg/dLãLDLã³ã¬ã¹ããã¼ã«202 mg/dLï¼ã«å¯¾ãã¦ã·ã³ãã¹ã¿ãã³80mg ãæä¸ããã¾ãããä½µç¨è¬ã¯æç¨ãã¦ãã¾ããã§
HSPã®å¿ãæ¯ãããL-ã¹ã¬ãªãã³é ¸ãã°ãã·ã¦ã ãã®åãã¨ã¯ï¼ HSPï¼Highly Sensitive Personï¼ââ äºæãéããç°å¢ãäººã®ææ ã«å½±é¿ãããããã ããã æ¥å¸¸ãçããã ãã§ç²ãã¦ãã¾ããã»ã©ã®ç¹ç´°ããæã¤äººãã¡ã ãã®ç¹ç´°ãªæåæ§ãæã¤è³ãããããæ¯ããæ¹æ³ã¨ãã¦ã L-ã¹ã¬ãªãã³é ¸ãã°ãã·ã¦ã ï¼Magnesium L-Threonateï¼ã¨ããæåããè¿å¹´æ³¨ç®ãéãã¦ãã¾ãã HSPã®è³ã«èµ·ãã£ã¦ããã㨠HSPã®æ¹ã¯ãåºæ¿ã«ææãªãããè³ã®ç¥çµåè·¯ãéæ´»åã«é¥ããããå¾åãããã¾ãã æ å ±å¦çã®ãªã¼ãã¼ãã¼ã ã¹ãã¬ã¹éå¤ã«ããè³ç²å´ ç¥çµä¼éã®ã¢ã³ãã©ã³ã¹ ç¡ç ã®è³ªã®ä½ä¸ãå復åã®ä½ä¸ ãããã¯ãã¹ã¦ãç¥çµã®åãã«é¢ä¸ããããã©ã«ããã°ãã·ã¦ã ãã®ä¸è¶³ã¨å¯æ¥ã«é¢ä¿ãã¦ãã¾ãã ãªãä¸è¬çãªãã°ãã·ã¦ã ã¯ãè³ãã«å±ããªãã®ãï¼ å£ããæåããããã°ãã·ã¦ã ã¯ä¸»ã«
人çã§ãããããªã絶対解ã«ã¨ããããªã åãçç²ã®ã²ã¼ã 好ãã§ãããã²ã¼ã ã¨ç¾å®ã®äººçã§ã¯ãä¸ã¤ã ã大ããéãç¹ãããã¾ãã ããã¯ã人çã«ã¯ç¨æããããæ£è§£ã®é¸æè¢ããåå¨ããªãã¨ãããã¨ã§ãã åãã¡ã¯å¾ã¦ãã¦ã人çã®é¸æã®å ´é¢ã«ããã¦ãééããé¸ã°ãªãããã¨ãä¸çªå¤§äºã ã¨æã£ã¦ãã¾ããã¡ã§ãã 妿 ¡ãå°±è·ããã¼ããã¼ããã¡ãã·ã§ã³ã«è³ãã¾ã§ããã®ãã¹ã¦ã«ããã¦ãããééãã®ãªã鏿ãããããã¨ããæ£ããçãæ¹ã§ãããã®ããã«æãã¦ãã¾ãã¾ãããã®èãã®è£ã«ã¯ãã鏿è¢ã®ä¸ã«ãæãæ£ããçãããããããããé¸ã³åããªããã°ãæãã¦ãã¾ãã®ã§ã¯ãªãããã¨ãã価å¤è¦³ãåå¨ãã¾ãã ãããã人çã®é¸æã«â絶対解âãªã©ããã¾ãããããã®ã¯âç´å¾è§£âã ãã§ãã çãã¥ãã人ã¯ãèªåã®é¸æã«ä¸å®ãå¾æãæ±ãã¦ãã¾ããèªåã®æ±ºæã«èªä¿¡ããªãã®ã§ãã©ããã§èª°ãã«æ±ºãã¦ããããã¨é¡ã£ãããå¤ãã®äººããæ£
ç±³ããµãã¥ã¼ã»ããç·åç é¢ãè±ããªã¹ãã«å¤§å¦ãªã©ã«æå±ããç ç©¶è ããçºè¡¨ããè«æãRole of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort studyãã¯ãä½ã®ççåå¿ãå¿ã®å¥åº·ã«ã©ã®ãããªå½±é¿ãä¸ããã®ãã調ã¹ãç ç©¶å ±åã ããççã¨ãã¤ç ãä¸å®çãèªç¥æ©è½ã®é¢ä¿ã«ã¤ãã¦ããªã©ã³ãã§5ä¸5098人ã対象ã¨ããå¤§è¦æ¨¡ç ç©¶ã宿½ããã ãç»åãè¦ããççãã¼ã«ã¼ã®éºä¼çãªã¹ã¯ã¹ã³ã¢ã¨æ°åãä¸å®é害ããã¸ãã£ãããã³ãã¬ãã£ããªææ ã¹ã³ã¢ã¨ã®é¢é£ãå ¨1æã ççã¨ã¯ãä½ãææãæå·ãã身ãå®ãããã®å ç«åå¿ã ãæ¥æ§ã®ççã¯å¿ è¦ãªé²å¾¡åå¿ã ããæ ¢æ§çã«ç¶ã軽度ã®ççã¯ãã¾ãã¾ãªç æ°ã¨
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}